Marian Nakada
Angel Investor @ Johnson & Johnson Robotics and Digital Solutions
Cambridge, United States
Marian Nakada is a Series C investor at Johnson & Johnson Robotics and Digital Solutions in Cambridge focused on Health Care and Therapeutics. Marian Nakada is based out of Cambridge, Massachusetts, and served as Vice President, Venture Investments of Johnson & Johnson Innovation. Marian previously worked at ONL Therapeutics as a Board Member. Marian Nakada attended Harvard University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Marian Nakada invests in
Stages Marian Nakada invests in
Countries Marian Nakada invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. The current market for retinal drugs is greater than $7 billion and rapidly growing. Existing therapies have significant limitations and none address the initial neural component of vision loss - the death of the photoreceptorcell. | $15M / Series C / Mar 08, 2023 |
Co-Investors
Johnson & Johnson Innovation is a center for science and business experts to collaborate with innovators to incorporate science into healthcare solutions, including medical device and diagnostic technologies, consumer healthcare products, and pharmaceuticals. It is focused on the advancement of new healthcare solutions in the consumer,pharmaceutical, and medical devices and diagnostics sectors.’The company provides financing tools that include early-stage research funding, seed funding, equity investments, licensing, and collaborations. Additionally, it offers its partners access to international markets, pricing and reimbursement, market testing, company creation services, and more. They conduct their activities with the help of regional incubators, satellite operations, single bench tops, modular labs, office space for entrepreneurs, and a year-round curriculum focused on business and drug development.Johnson & Johnson Innovation is a subsidiary of
Johnson & Johnson Robotics and Digital Solutions Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anjali Kumar
External Innovation Search & Evaluation
|
|||
Bruce Rosengard
Vice President
|
|||
Chris Picariello
President
|
|||
James J. Bergin
Vice President, Law
|
|||
|
John Magnasco
VP, Quality & Compliance, Robotics & Digital Solutions
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Marian Nakada invest in?
Marian Nakada invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series C stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Marian Nakada?
Public channels for Marian Nakada include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Marian Nakada last invest?
The most recent investment recorded for Marian Nakada closed in Mar 2023. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
